Annual CFI
-$130.07 M
+$59.88 M+31.53%
December 31, 2023
Summary
- As of February 7, 2025, RNA annual cash flow from investing activities is -$130.07 million, with the most recent change of +$59.88 million (+31.53%) on December 31, 2023.
- During the last 3 years, RNA annual CFI has fallen by -$122.28 million (-1570.78%).
- RNA annual CFI is now -265348.98% below its all-time high of -$49.00 thousand, reached on December 31, 2018.
Performance
RNA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$482.41 M
-$207.54 M-75.51%
September 1, 2024
Summary
- As of February 7, 2025, RNA quarterly cash flow from investing activities is -$482.41 million, with the most recent change of -$207.54 million (-75.51%) on September 1, 2024.
- Over the past year, RNA quarterly CFI has dropped by -$450.93 million (-1432.49%).
- RNA quarterly CFI is now -1045.17% below its all-time high of $51.04 million, reached on December 31, 2023.
Performance
RNA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$738.99 M
-$450.93 M-156.54%
September 1, 2024
Summary
- As of February 7, 2025, RNA TTM cash flow from investing activities is -$738.99 million, with the most recent change of -$450.93 million (-156.54%) on September 1, 2024.
- Over the past year, RNA TTM CFI has dropped by -$550.11 million (-291.25%).
- RNA TTM CFI is now -2348.70% below its all-time high of $32.86 million, reached on March 31, 2024.
Performance
RNA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
RNA Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.5% | -1432.5% | -291.3% |
| 3 y3 years | -1570.8% | -10000.0% | -10000.0% |
| 5 y5 years | -10000.0% | -10000.0% | -10000.0% |
RNA Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -57.6% | +31.5% | -1045.2% | at low | -2348.7% | at low |
| 5 y | 5-year | <-9999.0% | +31.5% | -1045.2% | at low | -2348.7% | at low |
| alltime | all time | <-9999.0% | +31.5% | -1045.2% | at low | -2348.7% | at low |
Avidity Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$482.41 M(+75.5%) | -$738.99 M(+156.5%) |
| Jun 2024 | - | -$274.87 M(+739.4%) | -$288.06 M(-976.5%) |
| Mar 2024 | - | -$32.75 M(-164.2%) | $32.86 M(-125.3%) |
| Dec 2023 | -$130.07 M(-31.5%) | $51.04 M(-262.1%) | -$130.07 M(-31.1%) |
| Sep 2023 | - | -$31.48 M(-168.4%) | -$188.88 M(+29.0%) |
| Jun 2023 | - | $46.05 M(-123.5%) | -$146.47 M(-30.3%) |
| Mar 2023 | - | -$195.68 M(+2419.1%) | -$210.16 M(+10.6%) |
| Dec 2022 | -$189.96 M(+130.2%) | -$7.77 M(-171.1%) | -$189.96 M(-28.7%) |
| Sep 2022 | - | $10.93 M(-162.0%) | -$266.25 M(-4.2%) |
| Jun 2022 | - | -$17.64 M(-89.9%) | -$277.98 M(+8.0%) |
| Mar 2022 | - | -$175.47 M(+108.7%) | -$257.47 M(+212.0%) |
| Dec 2021 | -$82.52 M | -$84.06 M(>+9900.0%) | -$82.52 M(+1432.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$800.00 K(-127.9%) | -$5.38 M(-0.8%) |
| Jun 2021 | - | $2.87 M(-647.0%) | -$5.43 M(-34.6%) |
| Mar 2021 | - | -$525.00 K(-92.4%) | -$8.30 M(+6.6%) |
| Dec 2020 | -$7.79 M(+3212.8%) | -$6.93 M(+720.1%) | -$7.79 M(+722.9%) |
| Sep 2020 | - | -$845.00 K(<-9900.0%) | -$946.00 K(+722.6%) |
| Jun 2020 | - | $0.00(-100.0%) | -$115.00 K(-53.1%) |
| Mar 2020 | - | -$10.00 K(-89.0%) | -$245.00 K(+4.3%) |
| Dec 2019 | -$235.00 K(+379.6%) | -$91.00 K(+550.0%) | -$235.00 K(+63.2%) |
| Sep 2019 | - | -$14.00 K(-89.2%) | -$144.00 K(+10.8%) |
| Jun 2019 | - | -$130.00 K(<-9900.0%) | -$130.00 K(<-9900.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
| Dec 2018 | -$49.00 K | - | - |
FAQ
- What is Avidity Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Avidity Biosciences?
- What is Avidity Biosciences annual CFI year-on-year change?
- What is Avidity Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Avidity Biosciences?
- What is Avidity Biosciences quarterly CFI year-on-year change?
- What is Avidity Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Avidity Biosciences?
- What is Avidity Biosciences TTM CFI year-on-year change?
What is Avidity Biosciences annual cash flow from investing activities?
The current annual CFI of RNA is -$130.07 M
What is the all time high annual CFI for Avidity Biosciences?
Avidity Biosciences all-time high annual cash flow from investing activities is -$49.00 K
What is Avidity Biosciences annual CFI year-on-year change?
Over the past year, RNA annual cash flow from investing activities has changed by +$59.88 M (+31.53%)
What is Avidity Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of RNA is -$482.41 M
What is the all time high quarterly CFI for Avidity Biosciences?
Avidity Biosciences all-time high quarterly cash flow from investing activities is $51.04 M
What is Avidity Biosciences quarterly CFI year-on-year change?
Over the past year, RNA quarterly cash flow from investing activities has changed by -$450.93 M (-1432.49%)
What is Avidity Biosciences TTM cash flow from investing activities?
The current TTM CFI of RNA is -$738.99 M
What is the all time high TTM CFI for Avidity Biosciences?
Avidity Biosciences all-time high TTM cash flow from investing activities is $32.86 M
What is Avidity Biosciences TTM CFI year-on-year change?
Over the past year, RNA TTM cash flow from investing activities has changed by -$550.11 M (-291.25%)